US Patent Issued to Rush University Medical Center, 149 Bio on May 6 for "Reagents and assays using modified integrin domains" (Florida, Illinois Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,562, issued on May 6, was assigned to Rush University Medical Center (Chicago) and 149 Bio LLC (Miami).

"Reagents and assays using modified integrin domains" was invented by Vineet Gupta (Chicago) and Antonio J. Barbosa (Ave Maria, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Modified integrin polypeptides are provided. Methods of identifying binding agents that bind to a modified integrin polypeptide are also provided."

The patent was filed on March 31, 2020, under Application No. 17/599,625.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=...